Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by GRAMPS1996on May 04, 2017 9:44am

175 Views

Post# 26202339

Insider Filings

Latest 10 SEDI filings for TLT within the last 6 months

Amended Filing

As of 11:59pm ET May 3rd, 2017

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Apr 26/17	Apr 18/17	Anderson, Guy John	Direct Ownership	Options	50 - Grant of options	100,000	$0.500
Apr 19/17	Apr 18/17	Bruder, Randall	Direct Ownership	Options	50 - Grant of options	100,000	$0.500
Apr 19/17	Apr 18/17	Perraton, Matthew Thomas	Direct Ownership	Options	50 - Grant of options	100,000	$0.500
Apr 18/17	Apr 18/17	Hachey, Kristina Maria	Direct Ownership	Options	50 - Grant of options	300,000	$0.500
Apr 18/17	Apr 18/17	Dumoulin-White, Roger John	Direct Ownership	Options	53 - Grant of warrants	2,000,000	$0.500
Apr 19/17	Apr 13/17	Bruder, Randall	Direct Ownership	Warrants	54 - Exercise of warrants	20,000	$0.380
Apr 19/17	Apr 13/17	Bruder, Randall	Direct Ownership	Warrants	54 - Exercise of warrants	-20,000	$0.380
Apr 18/17	Apr 13/17	Hachey, Kristina Maria	Direct Ownership	Common Shares	10 - Acquisition in the public market	50,000	$50,000.00
Apr 18/17	Apr 13/17	Hachey, Kristina Maria	Direct Ownership	Warrants	54 - Exercise of warrants	-50,000	$0.380
Apr 18/17	Apr 13/17	Dumoulin-White, Roger John	Direct Ownership	Common Shares	15 - Acquisition under a prospectus	102,500